Rebecca Capua

In a 2019 study published in the journal Nanotoxicology, researchers recreated the first phase of digestion in mice and fed them titanium dioxide, then examined whether accumulation occurred in the organs. Researchers wrote: “Significant accumulation of titanium was observed in the liver and intestine of E171-fed mice; in the latter a threefold increase in the number of TiO2 particles was also measured. Titanium accumulation in the liver was associated with necroinflammatory foci containing tissue monocytes/macrophages. Three days after the last dose, increased superoxide production and inflammation were observed in the stomach and intestine. Overall, [this] indicates that the risk for human health associated with dietary exposure to E171 needs to be carefully considered.”

Overall, buff percentage is a critical factor that manufacturers of titanium dioxide must carefully manage to ensure the quality, consistency, and cost-effectiveness of their products. By investing in advanced technology and processes to control buff percentage, manufacturers can meet the specific requirements of their customers and maintain a competitive edge in the market. As the demand for titanium dioxide continues to grow across various industries, manufacturers must continue to innovate and improve their processes to meet the evolving needs of their customers.